Tweenvest Stocks

Wuhan Keqian Biology Co.,Ltd (SHSE: 688526)

Health Care · Pharmaceuticals · CN

CN¥12.41

+0.57% today · -29.9% 1Y

Wuhan Keqian Biology Co.,Ltd (SHSE: 688526) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $859.53M and employs 935 people.

Over the last twelve months the share price has lost 29.9%, trading between 11.65 and 18.00.

Tweenvest scores Wuhan Keqian Biology Co.,Ltd across four factors: quality 75/100, value 71/100, growth 35/100, dividend 53/100. Its strongest factor is quality.

688526 price history

Not enough price history to draw a chart yet.

Key figures

Market cap
$859.53M
Revenue (TTM)
$123.11M
P/E
18.26
EPS
0.68
Dividend yield
5.16%
Beta (5Y)
0.35
52-week high
CN¥18.00
52-week low
CN¥11.65
Avg volume (3M)
—
Shares outstanding
463.92M
Employees
935
Next earnings
—

About Wuhan Keqian Biology Co.,Ltd

Wuhan Keqian Biology Co.,Ltd focuses on the research and development, production, sales, and animal epidemic prevention technical services of veterinary biological products in China. The company offers vaccines for pigs, poultry, and pets, as well as diagnostic reagents. Wuhan Keqian Biology Co.,Ltd was founded in 2001 and is based in Wuhan, China.

ISIN
CNE1000042Q8
Founded
2001
Listed since
Sep 22, 2020
Exchange
Shanghai Stock Exchange
Currency
CNY
CompanyMarket capPriceDay
Luye Pharma Group Ltd.SEHK: 2186$880.59MHK$1.73-5.46%
Mega Lifesciences Public Company LimitedSET: MEGA$876.99M฿33.75-2.88%
Chongqing Lummy Pharmaceutical Co., Ltd.SZSE: 300006$862.31MCN¥5.47-1.62%
Helus Pharma Inc.NasdaqGM: HELP$862.11M$11.80+10.07%
Zhejiang Int'l Group Co.,Ltd.SZSE: 000411$856.79MCN¥10.16+1.40%
Sanofi Consumer Healthcare India LimitedNSEI: SANOFICONR$852.33MRs3,581.70-0.52%
Guizhou Xinbang Pharmaceutical Co., Ltd.SZSE: 002390$852.21MCN¥3.01+1.69%
Sihuan Pharmaceutical Holdings Group Ltd.SEHK: 460$848.27MHK$0.74+2.78%

Browse every Pharmaceuticals company →

Figures last refreshed Oct 11, 2026.